Summary
Updated Aug 30, 2026
Celeste Rachelle Fralick is Director of Aspira Women's Health Inc. (AWHL). 1 SEC Form 4 filing on record, dated 2 October 2024.
Recent Transactions
1Every recent SEC Form 4 transaction Celeste Rachelle Fralick has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Celeste Rachelle Fralick files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jack W. Schuler - $600K of AWHL open-market activity in the last 12 months
- Jeffrey K. Cohen - $25K of AWHL open-market activity in the last 12 months
- John D. Fraser - $15K of AWHL open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Celeste Rachelle Fralick?
Celeste Rachelle Fralick is a corporate insider, tracked as Director of Aspira Women's Health Inc. (AWHL). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Celeste Rachelle Fralick last file a Form 4?
The only primary Form 4 on record is dated 2 October 2024.
Where can I see all of Celeste Rachelle Fralick's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Celeste Rachelle Fralick and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
